Do Hung N, Wang Jinan, Miao Yinglong
Center for Computational Biology and Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66047.
bioRxiv. 2023 Feb 2:2023.01.15.524128. doi: 10.1101/2023.01.15.524128.
G-protein-coupled receptors (GPCRs) are the largest superfamily of human membrane proteins and represent primary targets of ~1/3 of currently marketed drugs. Allosteric modulators have emerged as more selective drug candidates compared with orthosteric agonists and antagonists. However, many X-ray and cryo-EM structures of GPCRs resolved so far exhibit negligible differences upon binding of positive and negative allosteric modulators (PAMs and NAMs). Mechanism of dynamic allosteric modulation in GPCRs remains unclear. In this work, we have systematically mapped dynamic changes in free energy landscapes of GPCRs upon binding of allosteric modulators using the Gaussian accelerated molecular dynamics (GaMD), Deep Learning (DL) and free energy prOfiling Workflow (GLOW). A total of 18 available high-resolution experimental structures of allosteric modulator-bound class A and B GPCRs were collected for simulations. A number of 8 computational models were generated to examine selectivity of the modulators by changing their target receptors to different subtypes. All-atom GaMD simulations were performed for a total of 66 μs on 44 GPCR systems in the presence/absence of the modulator. DL and free energy calculations revealed significantly reduced conformational space of GPCRs upon modulator binding. While the modulator-free GPCRs often sampled multiple low-energy conformational states, the NAMs and PAMs confined the inactive and active agonist-G protein-bound GPCRs, respectively, to mostly only one specific conformation for signaling. Such cooperative effects were significantly reduced for binding of the selective modulators to "non-cognate" receptor subtypes in the computational models. Therefore, comprehensive DL of extensive GaMD simulations has revealed a general dynamic mechanism of GPCR allostery, which will greatly facilitate rational design of selective allosteric drugs of GPCRs.
G蛋白偶联受体(GPCRs)是人类膜蛋白中最大的超家族,是目前约三分之一上市药物的主要作用靶点。与正构激动剂和拮抗剂相比,变构调节剂已成为更具选择性的候选药物。然而,迄今为止解析的许多GPCRs的X射线和冷冻电镜结构在结合正变构调节剂(PAMs)和负变构调节剂(NAMs)时显示出微不足道的差异。GPCRs中动态变构调节的机制仍不清楚。在这项工作中,我们使用高斯加速分子动力学(GaMD)、深度学习(DL)和自由能分析工作流程(GLOW),系统地绘制了变构调节剂结合后GPCRs自由能景观的动态变化。总共收集了18个已有的变构调节剂结合的A类和B类GPCRs的高分辨率实验结构用于模拟。通过将其靶受体改变为不同亚型,生成了8个计算模型来研究调节剂的选择性。在有/无调节剂的情况下,对44个GPCR系统进行了总共66微秒的全原子GaMD模拟。DL和自由能计算表明,调节剂结合后GPCRs的构象空间显著减小。无调节剂的GPCRs通常会采样多种低能构象状态,而NAMs和PAMs分别将无活性和活性激动剂-G蛋白结合的GPCRs限制在大多仅一种特定的信号传导构象。在计算模型中,选择性调节剂与“非同源”受体亚型结合时,这种协同效应显著降低。因此,广泛的GaMD模拟的综合DL揭示了GPCR变构的一般动态机制,这将极大地促进GPCRs选择性变构药物的合理设计。